Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arthroplasty, Replacement, Knee | 69 | 2024 | 696 | 16.940 |
Why?
|
Arthroplasty, Replacement, Hip | 74 | 2023 | 863 | 15.000 |
Why?
|
Hip Prosthesis | 38 | 2023 | 605 | 8.980 |
Why?
|
Prosthesis Failure | 30 | 2023 | 556 | 6.020 |
Why?
|
Knee Prosthesis | 17 | 2024 | 248 | 5.700 |
Why?
|
Reoperation | 47 | 2024 | 932 | 5.470 |
Why?
|
Prosthesis Design | 28 | 2023 | 502 | 4.300 |
Why?
|
Knee Joint | 26 | 2024 | 797 | 4.030 |
Why?
|
Prosthesis-Related Infections | 16 | 2023 | 214 | 4.000 |
Why?
|
Postoperative Complications | 22 | 2019 | 957 | 3.880 |
Why?
|
Retrospective Studies | 53 | 2023 | 3272 | 3.520 |
Why?
|
Humans | 147 | 2024 | 29334 | 3.220 |
Why?
|
Osteoarthritis, Knee | 11 | 2021 | 381 | 3.210 |
Why?
|
Orthopedics | 6 | 2018 | 127 | 2.840 |
Why?
|
Hip Joint | 11 | 2016 | 367 | 2.660 |
Why?
|
Middle Aged | 68 | 2021 | 9817 | 2.610 |
Why?
|
Patient Satisfaction | 8 | 2020 | 294 | 2.510 |
Why?
|
Aged | 61 | 2023 | 9441 | 2.260 |
Why?
|
Internship and Residency | 7 | 2019 | 211 | 2.230 |
Why?
|
Treatment Outcome | 39 | 2023 | 3475 | 2.170 |
Why?
|
Tantalum | 8 | 2020 | 34 | 2.130 |
Why?
|
Male | 71 | 2021 | 15627 | 2.130 |
Why?
|
Female | 71 | 2021 | 16202 | 2.060 |
Why?
|
Joint Diseases | 4 | 2021 | 110 | 1.950 |
Why?
|
Arthritis, Infectious | 6 | 2023 | 59 | 1.860 |
Why?
|
Blood Loss, Surgical | 6 | 2017 | 64 | 1.830 |
Why?
|
Femoral Fractures | 5 | 2019 | 41 | 1.710 |
Why?
|
Synovial Fluid | 7 | 2023 | 123 | 1.640 |
Why?
|
Periprosthetic Fractures | 4 | 2019 | 32 | 1.600 |
Why?
|
Adult | 39 | 2024 | 8593 | 1.470 |
Why?
|
Radiography | 13 | 2017 | 678 | 1.470 |
Why?
|
Aged, 80 and over | 30 | 2023 | 4844 | 1.380 |
Why?
|
Sutures | 3 | 2015 | 41 | 1.350 |
Why?
|
Osteotomy | 6 | 2018 | 163 | 1.320 |
Why?
|
Orthopedic Surgeons | 2 | 2019 | 27 | 1.310 |
Why?
|
Femur | 13 | 2024 | 396 | 1.290 |
Why?
|
Tibia | 6 | 2021 | 259 | 1.280 |
Why?
|
Surgeons | 4 | 2023 | 76 | 1.230 |
Why?
|
Postoperative Period | 12 | 2020 | 288 | 1.200 |
Why?
|
Obesity, Morbid | 2 | 2020 | 73 | 1.200 |
Why?
|
Anti-Bacterial Agents | 5 | 2023 | 402 | 1.190 |
Why?
|
Orthopedic Procedures | 6 | 2019 | 317 | 1.180 |
Why?
|
Titanium | 9 | 2020 | 209 | 1.180 |
Why?
|
Blood Transfusion | 3 | 2017 | 64 | 1.160 |
Why?
|
Body Mass Index | 8 | 2019 | 426 | 1.140 |
Why?
|
Practice Guidelines as Topic | 3 | 2018 | 333 | 1.120 |
Why?
|
Clinical Competence | 6 | 2021 | 230 | 1.090 |
Why?
|
Fracture Fixation, Internal | 4 | 2019 | 71 | 1.080 |
Why?
|
Risk Factors | 15 | 2023 | 2436 | 1.050 |
Why?
|
Algorithms | 8 | 2022 | 400 | 1.040 |
Why?
|
Hip Fractures | 3 | 2018 | 32 | 1.020 |
Why?
|
Follow-Up Studies | 11 | 2020 | 1828 | 1.010 |
Why?
|
Knee Dislocation | 2 | 2015 | 7 | 1.000 |
Why?
|
Surgical Wound Infection | 5 | 2018 | 97 | 0.990 |
Why?
|
Femur Head | 5 | 2023 | 66 | 0.970 |
Why?
|
Machine Learning | 5 | 2022 | 54 | 0.970 |
Why?
|
United States | 17 | 2022 | 2331 | 0.960 |
Why?
|
Prospective Studies | 13 | 2021 | 1808 | 0.930 |
Why?
|
Osteoarthritis, Hip | 5 | 2018 | 94 | 0.930 |
Why?
|
Logistic Models | 4 | 2018 | 405 | 0.890 |
Why?
|
Surgery, Computer-Assisted | 3 | 2012 | 60 | 0.890 |
Why?
|
Suture Techniques | 2 | 2015 | 141 | 0.860 |
Why?
|
Arthroplasty, Replacement | 4 | 2021 | 147 | 0.860 |
Why?
|
Venous Thromboembolism | 2 | 2019 | 37 | 0.840 |
Why?
|
Metal-on-Metal Joint Prostheses | 3 | 2016 | 57 | 0.800 |
Why?
|
Operative Time | 5 | 2022 | 80 | 0.800 |
Why?
|
Education, Medical, Graduate | 3 | 2019 | 79 | 0.780 |
Why?
|
Knee | 2 | 2017 | 44 | 0.760 |
Why?
|
Hemostatics | 2 | 2017 | 11 | 0.740 |
Why?
|
Anticoagulants | 2 | 2019 | 100 | 0.700 |
Why?
|
Hemostasis, Surgical | 2 | 2016 | 15 | 0.700 |
Why?
|
Electrocoagulation | 2 | 2016 | 16 | 0.690 |
Why?
|
Range of Motion, Articular | 8 | 2019 | 699 | 0.690 |
Why?
|
Patellar Ligament | 3 | 2017 | 52 | 0.690 |
Why?
|
Arthralgia | 3 | 2016 | 121 | 0.690 |
Why?
|
Mobile Applications | 1 | 2019 | 24 | 0.680 |
Why?
|
Hip Dislocation | 1 | 2020 | 65 | 0.680 |
Why?
|
Preoperative Care | 2 | 2016 | 135 | 0.680 |
Why?
|
Physician Assistants | 1 | 2019 | 18 | 0.680 |
Why?
|
Betacoronavirus | 1 | 2020 | 75 | 0.680 |
Why?
|
Patella | 2 | 2018 | 81 | 0.670 |
Why?
|
Antibiotic Prophylaxis | 2 | 2016 | 36 | 0.660 |
Why?
|
Inventions | 1 | 2018 | 3 | 0.660 |
Why?
|
Entrepreneurship | 1 | 2018 | 4 | 0.660 |
Why?
|
Patient Care | 1 | 2018 | 34 | 0.650 |
Why?
|
Research | 2 | 2017 | 54 | 0.650 |
Why?
|
Clinical Decision-Making | 1 | 2018 | 36 | 0.650 |
Why?
|
Femur Head Necrosis | 2 | 2011 | 9 | 0.640 |
Why?
|
Ambulatory Care | 1 | 2018 | 75 | 0.640 |
Why?
|
Coronavirus Infections | 1 | 2020 | 86 | 0.640 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 89 | 0.640 |
Why?
|
Societies, Medical | 3 | 2018 | 190 | 0.640 |
Why?
|
Antifibrinolytic Agents | 2 | 2017 | 23 | 0.630 |
Why?
|
Pandemics | 1 | 2020 | 235 | 0.630 |
Why?
|
Tranexamic Acid | 2 | 2017 | 23 | 0.630 |
Why?
|
Medicaid | 2 | 2017 | 37 | 0.620 |
Why?
|
Aprotinin | 1 | 2017 | 2 | 0.620 |
Why?
|
Patient Care Bundles | 1 | 2017 | 5 | 0.620 |
Why?
|
Fibrin Tissue Adhesive | 1 | 2017 | 8 | 0.620 |
Why?
|
Ankle Fractures | 1 | 2017 | 1 | 0.610 |
Why?
|
Open Fracture Reduction | 1 | 2017 | 3 | 0.610 |
Why?
|
Knee Injuries | 2 | 2017 | 223 | 0.610 |
Why?
|
Postoperative Hemorrhage | 1 | 2017 | 24 | 0.600 |
Why?
|
Nurse Practitioners | 1 | 2019 | 105 | 0.600 |
Why?
|
Efficiency | 1 | 2017 | 15 | 0.600 |
Why?
|
Acetabulum | 4 | 2016 | 208 | 0.600 |
Why?
|
Cobalt | 3 | 2023 | 116 | 0.590 |
Why?
|
Cost Savings | 2 | 2017 | 36 | 0.590 |
Why?
|
Bone Cements | 2 | 2016 | 99 | 0.590 |
Why?
|
Corrosion | 7 | 2023 | 139 | 0.590 |
Why?
|
Injections, Intra-Articular | 1 | 2017 | 88 | 0.580 |
Why?
|
Hospital Costs | 1 | 2017 | 68 | 0.580 |
Why?
|
Argon Plasma Coagulation | 1 | 2016 | 1 | 0.580 |
Why?
|
Publishing | 1 | 2017 | 38 | 0.570 |
Why?
|
Staphylococcal Infections | 3 | 2017 | 176 | 0.570 |
Why?
|
Kaplan-Meier Estimate | 5 | 2018 | 162 | 0.560 |
Why?
|
Survivorship | 3 | 2020 | 17 | 0.560 |
Why?
|
Polyethylene | 3 | 2016 | 116 | 0.560 |
Why?
|
Chromium | 2 | 2013 | 92 | 0.550 |
Why?
|
Cefuroxime | 1 | 2015 | 2 | 0.550 |
Why?
|
Alloys | 2 | 2013 | 102 | 0.550 |
Why?
|
Cefazolin | 1 | 2015 | 5 | 0.550 |
Why?
|
Cell Count | 1 | 2015 | 99 | 0.540 |
Why?
|
Sleep Wake Disorders | 1 | 2017 | 148 | 0.540 |
Why?
|
Anesthesia, Spinal | 1 | 2015 | 18 | 0.540 |
Why?
|
Evidence-Based Medicine | 2 | 2014 | 208 | 0.530 |
Why?
|
Educational Measurement | 2 | 2019 | 59 | 0.530 |
Why?
|
Anesthesia, Epidural | 1 | 2015 | 25 | 0.530 |
Why?
|
Anesthesia, General | 1 | 2015 | 30 | 0.530 |
Why?
|
Biocompatible Materials | 3 | 2017 | 114 | 0.530 |
Why?
|
Databases, Factual | 5 | 2018 | 330 | 0.510 |
Why?
|
Journal Impact Factor | 1 | 2014 | 15 | 0.500 |
Why?
|
Time Factors | 9 | 2019 | 1614 | 0.500 |
Why?
|
Length of Stay | 4 | 2021 | 317 | 0.490 |
Why?
|
Surveys and Questionnaires | 6 | 2019 | 1181 | 0.490 |
Why?
|
Sleep | 1 | 2017 | 313 | 0.480 |
Why?
|
Medicare | 6 | 2022 | 121 | 0.480 |
Why?
|
Periodicals as Topic | 1 | 2014 | 41 | 0.480 |
Why?
|
Hemiarthroplasty | 1 | 2014 | 31 | 0.470 |
Why?
|
Porosity | 5 | 2020 | 71 | 0.470 |
Why?
|
Osseointegration | 4 | 2017 | 76 | 0.430 |
Why?
|
Metals | 4 | 2015 | 160 | 0.430 |
Why?
|
Recovery of Function | 5 | 2018 | 290 | 0.430 |
Why?
|
Radiographic Image Enhancement | 1 | 2012 | 16 | 0.430 |
Why?
|
Health Care Costs | 1 | 2012 | 70 | 0.430 |
Why?
|
Professional Competence | 1 | 2012 | 39 | 0.410 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2010 | 27 | 0.390 |
Why?
|
Chromium Alloys | 5 | 2023 | 48 | 0.380 |
Why?
|
Risk Assessment | 5 | 2018 | 678 | 0.380 |
Why?
|
Suction | 3 | 2015 | 41 | 0.370 |
Why?
|
Odds Ratio | 4 | 2018 | 284 | 0.360 |
Why?
|
Arthropathy, Neurogenic | 1 | 2009 | 1 | 0.360 |
Why?
|
Exercise Movement Techniques | 1 | 2009 | 1 | 0.350 |
Why?
|
Patient Preference | 2 | 2019 | 33 | 0.330 |
Why?
|
Patient Readmission | 2 | 2021 | 123 | 0.330 |
Why?
|
Demography | 2 | 2019 | 77 | 0.320 |
Why?
|
Joint Instability | 2 | 2012 | 387 | 0.320 |
Why?
|
Comorbidity | 4 | 2017 | 497 | 0.320 |
Why?
|
Body Weight | 2 | 2019 | 133 | 0.310 |
Why?
|
Quality Improvement | 4 | 2018 | 158 | 0.310 |
Why?
|
Exercise Therapy | 2 | 2019 | 112 | 0.310 |
Why?
|
Propensity Score | 2 | 2018 | 34 | 0.310 |
Why?
|
Risk Adjustment | 2 | 2018 | 12 | 0.310 |
Why?
|
Linear Models | 2 | 2018 | 254 | 0.300 |
Why?
|
Ganglion Cysts | 1 | 2006 | 5 | 0.300 |
Why?
|
Physical Therapy Modalities | 2 | 2019 | 80 | 0.300 |
Why?
|
Wrist | 1 | 2006 | 17 | 0.300 |
Why?
|
Predictive Value of Tests | 3 | 2021 | 521 | 0.290 |
Why?
|
Prosthesis Fitting | 2 | 2020 | 22 | 0.290 |
Why?
|
Postoperative Care | 2 | 2019 | 127 | 0.290 |
Why?
|
Ossification, Heterotopic | 1 | 2006 | 42 | 0.290 |
Why?
|
Guided Tissue Regeneration | 1 | 2006 | 11 | 0.290 |
Why?
|
Ceramics | 2 | 2018 | 23 | 0.280 |
Why?
|
Patient Reported Outcome Measures | 2 | 2020 | 379 | 0.270 |
Why?
|
Reproducibility of Results | 5 | 2021 | 788 | 0.270 |
Why?
|
Humeral Fractures | 1 | 2005 | 22 | 0.260 |
Why?
|
Biomechanical Phenomena | 2 | 2018 | 668 | 0.260 |
Why?
|
Current Procedural Terminology | 2 | 2022 | 13 | 0.260 |
Why?
|
Wounds and Injuries | 2 | 2016 | 44 | 0.260 |
Why?
|
Shoulder Fractures | 1 | 2005 | 26 | 0.260 |
Why?
|
Registries | 3 | 2021 | 187 | 0.260 |
Why?
|
Prostheses and Implants | 1 | 2006 | 166 | 0.250 |
Why?
|
Calibration | 2 | 2016 | 22 | 0.250 |
Why?
|
Simulation Training | 2 | 2021 | 34 | 0.240 |
Why?
|
Multivariate Analysis | 4 | 2017 | 324 | 0.230 |
Why?
|
Signal Transduction | 2 | 2016 | 486 | 0.230 |
Why?
|
Elective Surgical Procedures | 2 | 2020 | 43 | 0.230 |
Why?
|
Arthroplasty | 3 | 2018 | 136 | 0.220 |
Why?
|
Femoral Neck Fractures | 2 | 2015 | 13 | 0.220 |
Why?
|
Computer Simulation | 2 | 2021 | 218 | 0.220 |
Why?
|
Patient Discharge | 3 | 2019 | 149 | 0.210 |
Why?
|
Denmark | 1 | 2021 | 12 | 0.210 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2021 | 13 | 0.200 |
Why?
|
Surgical Wound | 2 | 2018 | 11 | 0.200 |
Why?
|
Social Class | 1 | 2021 | 64 | 0.190 |
Why?
|
Therapeutic Irrigation | 2 | 2019 | 66 | 0.190 |
Why?
|
Adolescent | 4 | 2018 | 2274 | 0.190 |
Why?
|
Wound Healing | 4 | 2018 | 168 | 0.190 |
Why?
|
Joint Prosthesis | 1 | 2021 | 83 | 0.190 |
Why?
|
Equipment Design | 3 | 2011 | 184 | 0.190 |
Why?
|
Case-Control Studies | 1 | 2022 | 636 | 0.190 |
Why?
|
Joint Dislocations | 2 | 2018 | 57 | 0.190 |
Why?
|
Leukocyte Count | 3 | 2016 | 92 | 0.180 |
Why?
|
Incidence | 3 | 2017 | 752 | 0.180 |
Why?
|
Rivaroxaban | 1 | 2019 | 8 | 0.180 |
Why?
|
Warfarin | 1 | 2019 | 37 | 0.180 |
Why?
|
Debridement | 2 | 2017 | 100 | 0.170 |
Why?
|
Quality of Health Care | 2 | 2018 | 138 | 0.170 |
Why?
|
Inpatients | 2 | 2019 | 141 | 0.170 |
Why?
|
Sensitivity and Specificity | 3 | 2023 | 552 | 0.170 |
Why?
|
Biomarkers | 3 | 2023 | 690 | 0.170 |
Why?
|
Video Recording | 1 | 2019 | 47 | 0.170 |
Why?
|
Patient Selection | 2 | 2014 | 232 | 0.170 |
Why?
|
Text Messaging | 1 | 2019 | 14 | 0.170 |
Why?
|
Health Personnel | 1 | 2020 | 115 | 0.170 |
Why?
|
Child, Preschool | 1 | 2020 | 641 | 0.170 |
Why?
|
Fracture Healing | 3 | 2010 | 40 | 0.170 |
Why?
|
Aspirin | 1 | 2019 | 83 | 0.170 |
Why?
|
Young Adult | 4 | 2018 | 1933 | 0.170 |
Why?
|
Osteophyte | 1 | 2018 | 6 | 0.170 |
Why?
|
Delivery of Health Care | 1 | 2020 | 152 | 0.170 |
Why?
|
Arthrometry, Articular | 1 | 2018 | 14 | 0.170 |
Why?
|
Professional-Patient Relations | 1 | 2018 | 28 | 0.170 |
Why?
|
Health Care Surveys | 1 | 2018 | 67 | 0.170 |
Why?
|
Intellectual Property | 1 | 2018 | 2 | 0.170 |
Why?
|
Forecasting | 1 | 2018 | 117 | 0.170 |
Why?
|
Physician-Patient Relations | 1 | 2018 | 39 | 0.160 |
Why?
|
Venous Thrombosis | 2 | 2017 | 42 | 0.160 |
Why?
|
Negative-Pressure Wound Therapy | 1 | 2018 | 4 | 0.160 |
Why?
|
Concept Formation | 1 | 2018 | 11 | 0.160 |
Why?
|
Manipulation, Orthopedic | 1 | 2018 | 10 | 0.160 |
Why?
|
Operating Rooms | 1 | 2018 | 14 | 0.160 |
Why?
|
Minimally Invasive Surgical Procedures | 3 | 2012 | 300 | 0.160 |
Why?
|
Guideline Adherence | 1 | 2018 | 67 | 0.160 |
Why?
|
Mentors | 1 | 2018 | 47 | 0.160 |
Why?
|
Anesthesia | 1 | 2018 | 34 | 0.160 |
Why?
|
Regression Analysis | 4 | 2022 | 297 | 0.160 |
Why?
|
Physical Examination | 1 | 2018 | 117 | 0.150 |
Why?
|
Fracture Fixation | 2 | 2015 | 24 | 0.150 |
Why?
|
Data Collection | 1 | 2018 | 107 | 0.150 |
Why?
|
Patient Education as Topic | 1 | 2019 | 162 | 0.150 |
Why?
|
Accreditation | 1 | 2017 | 16 | 0.150 |
Why?
|
Administration, Intravenous | 1 | 2017 | 29 | 0.150 |
Why?
|
Health Expenditures | 1 | 2017 | 19 | 0.150 |
Why?
|
Insurance Coverage | 1 | 2017 | 13 | 0.150 |
Why?
|
Calcium Sulfate | 1 | 2017 | 19 | 0.150 |
Why?
|
Health Resources | 1 | 2017 | 24 | 0.150 |
Why?
|
Viscosupplements | 1 | 2017 | 11 | 0.150 |
Why?
|
Animals | 5 | 2016 | 4577 | 0.150 |
Why?
|
Preoperative Period | 1 | 2017 | 65 | 0.150 |
Why?
|
Workload | 1 | 2017 | 33 | 0.150 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2017 | 28 | 0.150 |
Why?
|
Leg Length Inequality | 1 | 2016 | 12 | 0.150 |
Why?
|
Pulmonary Embolism | 1 | 2017 | 59 | 0.150 |
Why?
|
Personality | 1 | 2017 | 68 | 0.150 |
Why?
|
Hemoglobins | 1 | 2017 | 81 | 0.150 |
Why?
|
Pain | 2 | 2019 | 391 | 0.140 |
Why?
|
Activities of Daily Living | 1 | 2020 | 501 | 0.140 |
Why?
|
Child | 1 | 2020 | 1344 | 0.140 |
Why?
|
Femur Neck | 1 | 2016 | 18 | 0.140 |
Why?
|
Analysis of Variance | 1 | 2017 | 321 | 0.140 |
Why?
|
Device Removal | 2 | 2016 | 85 | 0.140 |
Why?
|
Protein Kinase C-delta | 1 | 2016 | 11 | 0.140 |
Why?
|
Adrenal Cortex Hormones | 1 | 2017 | 100 | 0.140 |
Why?
|
Casts, Surgical | 1 | 2015 | 8 | 0.140 |
Why?
|
Axons | 1 | 2016 | 38 | 0.140 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2016 | 65 | 0.140 |
Why?
|
Intraoperative Period | 1 | 2015 | 29 | 0.140 |
Why?
|
Surgical Flaps | 1 | 2016 | 49 | 0.140 |
Why?
|
Rupture, Spontaneous | 1 | 2015 | 6 | 0.130 |
Why?
|
International Normalized Ratio | 1 | 2015 | 23 | 0.130 |
Why?
|
Chicago | 1 | 2018 | 865 | 0.130 |
Why?
|
Pain, Postoperative | 1 | 2019 | 314 | 0.130 |
Why?
|
Tendon Injuries | 1 | 2017 | 196 | 0.130 |
Why?
|
Rupture | 1 | 2015 | 115 | 0.130 |
Why?
|
Ganglia, Spinal | 2 | 2016 | 57 | 0.130 |
Why?
|
Hemodilution | 1 | 2014 | 2 | 0.130 |
Why?
|
Laser Coagulation | 1 | 2014 | 5 | 0.130 |
Why?
|
Blood Component Transfusion | 1 | 2014 | 3 | 0.130 |
Why?
|
Pneumonia | 1 | 2015 | 67 | 0.130 |
Why?
|
Tourniquets | 1 | 2014 | 3 | 0.130 |
Why?
|
Reading | 1 | 2014 | 40 | 0.130 |
Why?
|
Bibliometrics | 1 | 2014 | 24 | 0.120 |
Why?
|
Mass Screening | 1 | 2016 | 177 | 0.120 |
Why?
|
Hospitalization | 1 | 2017 | 317 | 0.120 |
Why?
|
Age Factors | 1 | 2017 | 839 | 0.120 |
Why?
|
Morbidity | 1 | 2014 | 63 | 0.120 |
Why?
|
Bandages | 1 | 2013 | 8 | 0.120 |
Why?
|
ROC Curve | 3 | 2021 | 138 | 0.120 |
Why?
|
Medical Errors | 1 | 2014 | 28 | 0.120 |
Why?
|
Kidney Diseases | 1 | 2015 | 115 | 0.120 |
Why?
|
Observer Variation | 1 | 2014 | 118 | 0.120 |
Why?
|
Allografts | 1 | 2015 | 179 | 0.120 |
Why?
|
Magnetic Resonance Imaging | 2 | 2012 | 1222 | 0.120 |
Why?
|
Blood Sedimentation | 3 | 2021 | 64 | 0.120 |
Why?
|
Bone Resorption | 1 | 2014 | 104 | 0.120 |
Why?
|
Mass Spectrometry | 1 | 2013 | 41 | 0.110 |
Why?
|
C-Reactive Protein | 3 | 2021 | 125 | 0.110 |
Why?
|
Double-Blind Method | 1 | 2014 | 503 | 0.110 |
Why?
|
Bone Remodeling | 1 | 2013 | 44 | 0.110 |
Why?
|
Hypertension | 1 | 2015 | 266 | 0.110 |
Why?
|
Granuloma, Plasma Cell | 1 | 2012 | 3 | 0.110 |
Why?
|
Neoplasms | 1 | 2015 | 245 | 0.110 |
Why?
|
Stainless Steel | 1 | 2012 | 17 | 0.110 |
Why?
|
Cost-Benefit Analysis | 1 | 2012 | 144 | 0.110 |
Why?
|
Physicians | 1 | 2014 | 115 | 0.110 |
Why?
|
Reimbursement Mechanisms | 1 | 2012 | 13 | 0.110 |
Why?
|
Osteoarthritis | 1 | 2016 | 363 | 0.100 |
Why?
|
Arthroscopy | 1 | 2018 | 811 | 0.100 |
Why?
|
Cohort Studies | 3 | 2017 | 1936 | 0.100 |
Why?
|
Nociceptors | 1 | 2010 | 19 | 0.100 |
Why?
|
Fractures, Ununited | 1 | 2010 | 19 | 0.100 |
Why?
|
Internal Fixators | 1 | 2010 | 54 | 0.090 |
Why?
|
Spinal Cord | 1 | 2010 | 103 | 0.090 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2012 | 193 | 0.090 |
Why?
|
Kidney Failure, Chronic | 1 | 2011 | 161 | 0.090 |
Why?
|
Curriculum | 2 | 2021 | 155 | 0.080 |
Why?
|
Severity of Illness Index | 3 | 2019 | 1110 | 0.080 |
Why?
|
Surface Properties | 2 | 2020 | 144 | 0.080 |
Why?
|
Arthritis, Psoriatic | 1 | 2008 | 17 | 0.080 |
Why?
|
Bone Screws | 2 | 2008 | 181 | 0.080 |
Why?
|
Connective Tissue | 1 | 2007 | 25 | 0.080 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2007 | 2 | 0.080 |
Why?
|
Pain Management | 2 | 2019 | 143 | 0.080 |
Why?
|
Contraindications | 1 | 2007 | 41 | 0.070 |
Why?
|
Proportional Hazards Models | 2 | 2018 | 339 | 0.070 |
Why?
|
Materials Testing | 1 | 2007 | 137 | 0.070 |
Why?
|
Fluoroscopy | 1 | 2007 | 52 | 0.070 |
Why?
|
Sports | 1 | 2007 | 36 | 0.070 |
Why?
|
Guidelines as Topic | 1 | 2007 | 67 | 0.070 |
Why?
|
Prognosis | 2 | 2008 | 839 | 0.070 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2008 | 124 | 0.070 |
Why?
|
Bone Nails | 2 | 2020 | 17 | 0.070 |
Why?
|
Muscle Strength | 1 | 2007 | 127 | 0.070 |
Why?
|
Walking | 1 | 2008 | 252 | 0.070 |
Why?
|
Injury Severity Score | 1 | 2005 | 15 | 0.070 |
Why?
|
Rare Diseases | 1 | 2005 | 11 | 0.070 |
Why?
|
Clinical Trials as Topic | 1 | 2006 | 324 | 0.060 |
Why?
|
Lower Extremity | 1 | 2024 | 38 | 0.060 |
Why?
|
Longitudinal Studies | 1 | 2008 | 1442 | 0.060 |
Why?
|
Athletic Injuries | 1 | 2005 | 178 | 0.060 |
Why?
|
Vitallium | 1 | 2023 | 25 | 0.060 |
Why?
|
Pain Measurement | 1 | 2005 | 462 | 0.060 |
Why?
|
Chi-Square Distribution | 2 | 2016 | 145 | 0.050 |
Why?
|
Survival Analysis | 1 | 2021 | 297 | 0.050 |
Why?
|
Finite Element Analysis | 1 | 2020 | 44 | 0.050 |
Why?
|
Arthrodesis | 1 | 2020 | 40 | 0.050 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2019 | 14 | 0.050 |
Why?
|
Stress, Mechanical | 1 | 2020 | 166 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2021 | 101 | 0.050 |
Why?
|
Povidone-Iodine | 1 | 2019 | 8 | 0.050 |
Why?
|
Pain Perception | 1 | 2019 | 7 | 0.040 |
Why?
|
Early Ambulation | 1 | 2019 | 20 | 0.040 |
Why?
|
Learning Curve | 1 | 2019 | 18 | 0.040 |
Why?
|
Narcotics | 1 | 2019 | 34 | 0.040 |
Why?
|
Mentoring | 1 | 2019 | 29 | 0.040 |
Why?
|
Surgical Wound Dehiscence | 1 | 2018 | 9 | 0.040 |
Why?
|
Data Mining | 1 | 2017 | 4 | 0.040 |
Why?
|
Hand | 1 | 2018 | 45 | 0.040 |
Why?
|
Drainage | 1 | 2018 | 50 | 0.040 |
Why?
|
Disease-Free Survival | 1 | 2018 | 175 | 0.040 |
Why?
|
Area Under Curve | 1 | 2017 | 66 | 0.040 |
Why?
|
Interprofessional Relations | 1 | 2017 | 34 | 0.040 |
Why?
|
Faculty, Medical | 1 | 2017 | 38 | 0.040 |
Why?
|
Spine | 1 | 2018 | 121 | 0.040 |
Why?
|
Program Evaluation | 1 | 2017 | 132 | 0.040 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2016 | 86 | 0.040 |
Why?
|
Staphylococcus aureus | 1 | 2017 | 85 | 0.040 |
Why?
|
Self Concept | 1 | 2016 | 45 | 0.040 |
Why?
|
Transplantation, Homologous | 1 | 2017 | 277 | 0.040 |
Why?
|
Acute Disease | 1 | 2017 | 225 | 0.040 |
Why?
|
Skin Transplantation | 1 | 2016 | 16 | 0.040 |
Why?
|
Blood Glucose | 1 | 2017 | 112 | 0.040 |
Why?
|
Equipment Failure Analysis | 1 | 2016 | 106 | 0.040 |
Why?
|
Receptor, trkA | 1 | 2016 | 8 | 0.040 |
Why?
|
Sensory Receptor Cells | 1 | 2016 | 7 | 0.040 |
Why?
|
Communication | 1 | 2017 | 111 | 0.040 |
Why?
|
Treatment Failure | 1 | 2016 | 159 | 0.040 |
Why?
|
Recurrence | 1 | 2017 | 348 | 0.040 |
Why?
|
Attitude of Health Personnel | 1 | 2017 | 148 | 0.030 |
Why?
|
Nerve Growth Factor | 1 | 2016 | 31 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2017 | 138 | 0.030 |
Why?
|
Synovial Membrane | 1 | 2016 | 80 | 0.030 |
Why?
|
Neutrophils | 1 | 2016 | 114 | 0.030 |
Why?
|
Quality Assurance, Health Care | 1 | 2015 | 49 | 0.030 |
Why?
|
Arthritis, Rheumatoid | 1 | 2019 | 357 | 0.030 |
Why?
|
Risk | 1 | 2015 | 217 | 0.030 |
Why?
|
Hospital Mortality | 1 | 2015 | 141 | 0.030 |
Why?
|
Occlusive Dressings | 1 | 2014 | 2 | 0.030 |
Why?
|
Wound Closure Techniques | 1 | 2014 | 9 | 0.030 |
Why?
|
Mutation | 1 | 2016 | 383 | 0.030 |
Why?
|
Bacteriological Techniques | 1 | 2013 | 20 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 958 | 0.030 |
Why?
|
Insurance, Health | 1 | 2013 | 22 | 0.030 |
Why?
|
Random Allocation | 1 | 2013 | 146 | 0.030 |
Why?
|
California | 1 | 2012 | 31 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2016 | 729 | 0.030 |
Why?
|
Fees and Charges | 1 | 2012 | 7 | 0.030 |
Why?
|
Bone Malalignment | 1 | 2011 | 20 | 0.030 |
Why?
|
Prevalence | 1 | 2013 | 486 | 0.030 |
Why?
|
Mice | 1 | 2016 | 1608 | 0.020 |
Why?
|
Population Surveillance | 1 | 2012 | 116 | 0.020 |
Why?
|
Equipment Failure | 1 | 2010 | 51 | 0.020 |
Why?
|
Educational Status | 1 | 2012 | 295 | 0.020 |
Why?
|
Arthritis, Experimental | 1 | 2010 | 125 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2010 | 452 | 0.020 |
Why?
|
Chondrocytes | 1 | 2010 | 197 | 0.020 |
Why?
|
Fracture Fixation, Intramedullary | 1 | 2008 | 9 | 0.020 |
Why?
|
Traction | 1 | 2008 | 28 | 0.020 |
Why?
|
Bone Plates | 1 | 2008 | 54 | 0.020 |
Why?
|
Rats | 1 | 2010 | 857 | 0.020 |
Why?
|
Blood Transfusion, Autologous | 1 | 2007 | 3 | 0.020 |
Why?
|
Erythrocyte Transfusion | 1 | 2007 | 20 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2008 | 100 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2008 | 339 | 0.020 |
Why?
|
Internet | 1 | 2007 | 91 | 0.020 |
Why?
|